Nitric oxide metabolities in acute rheumatic fever


Creative Commons License

Narin F., Narin N., Pasaoglu H., Halici C., Aslan D.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, cilt.199, sa.3, ss.135-139, 2003 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 199 Sayı: 3
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1620/tjem.199.135
  • Dergi Adı: TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.135-139
  • Erciyes Üniversitesi Adresli: Evet

Özet

Acute rheumatic fever (ARF), is a systemic inflammatory disease etiologically related to infection with group A beta hemolytic streptococcus, characterized by a broad spectrum of disorders in cellular immunity. To estimate the activity of the immunopathological process in patients with ARF, plasma nitric oxide metabolities (NOx) concentrations, IL-1alpha and IL-2 levels were investigated in 22 patients with ARF at the time on admission, and after 3 months, in children with chronic rheumatic heart disease (CRHD). Plasma NOx concentrations, IL-1alpha and IL/2 levels in patients with ARF on admission were significantly higher than in the same patients 3 months later, and higher than in CRHD, or controls. Increased plasma NO may be a useful index for the quantitative assessment of the activity during immunological challange. This information may be useful for the prognosis and monitoring of ARK. (C) 2003 Tohoku University Medical Press.